Abstract:Glaucoma is a progressive neuropathy characterized by loss of vision as a result of the death of retinal ganglion cells (RGCs). There are currently no effective neuroprotectants to treat this disorder. In this series of studies, we used LINGO-1 antagonists, Nogo-66 receptor (NgR1) antagonists, sNgR-Fc, and brain-derived neurotrophic factor (BDNF) to study the neuroprotection of RGCs in a rat glaucoma model with chronic ocular hypertension. LINGO-1 is a functional member of the NgR1/TROY and the P75 signaling complexes that prevent axonal regeneration by activating RhoA in the central nervous system (CNS). NgR1 mediates the inhibition of axonal regeneration in the presence of three myelin proteins including Nogo-A, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein in the CNS. LINGO-1 was expressed in RGCs and increased after the induction of ocular hypertension. Blocking LINGO-1 function with LINGO-1 soluble protein, LINGO-1-Fc, and LINGO-1 mAb 1A7 significantly promoted RGC survival 2 and 4 weeks after the induction of ocular hypertension and also after optic nerve transection. LINGO-1 formed a receptor complex with TrkB and negatively regulated its activation in the retina after ocular hypertension injury. Blocking LINGO-1 function with LINGO-1-Fc or 1A7 upregulated TrkB phosphorylation after high intraocular pressure injury. BDNF antibody significantly blocked the neuroprotection of LINGO-1-Fc on RGC survival. Similarly, in combination with BDNF, LINGO-1-Fc provided significantly more protection to RGCs in the 4-week glaucoma animals. Thus, LINGO-1 antagonists protect RGCs by regulating the BDNF and TrkB signaling in glaucoma. NgR1 was expressed in RGCs and increased after the induction of ocular hypertension. There was synaptic degeneration of RGCs already detected in the early stage under the elevated intraocular pressure, which preceded cell death in the early stage. The upregulation of Nogo-A may be a possible mechanism of RGC death and synapse degeneration in glaucoma. Soluble (s) NgR-Fc significantly promoted RGC survival at 2 and 4 weeks after ocular hypertension and also after optic nerve transection. Furthermore, sNgR-Fc relieved synaptic degeneration at 5 days, and at 2 and 4 weeks. This suggests that there indeed may be an opportunity to rescue RGCs that are undergoing synaptic alteration, but not yet committed to die. These data suggest that the antagonists of LINGO-1 and NgR1 may provide an attractive therapeutic strategy to prevent the degeneration of RGCs and synapses in glaucoma.

Lhx2 promotes axon regeneration of adult retinal ganglion cells and rescues neurodegeneration in mouse models of glaucoma

Single-cell transcriptome analysis of regenerating RGCs reveals potent glaucoma neural repair genes

Advances in Regeneration of Retinal Ganglion Cells and Optic Nerves

Soluble Nogo-66 Receptor Prevents Synaptic Dysfunction And Rescues Retinal Ganglion Cell Loss In Chronic Glaucoma

Srgap2 suppression ameliorates retinal ganglion cell degeneration in mice

Comparative proteomic analysis of regenerative mechanisms in mouse retina to identify markers for neuro-regeneration in glaucoma

Neuroprotection of Retinal Ganglion Cells in Glaucoma by Blocking Lingo-1 Function or Using A Nogo-66 Receptor Antagonist

Promoting axon regeneration in the adult CNS by modulation of the melanopsin/GPCR signaling

<i>Srgap2</i> suppression ameliorates retinal ganglion cell degeneration in mice

Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules

Protective Effects of Lipoxin A and B Signaling on the Inner Retina in a Mouse Model of Experimental Glaucoma

Towards Retinal Ganglion Cell Regeneration

NMNAT2 is Downregulated in Glaucomatous RGCs, and RGC-specific Gene Therapy Rescues Neurodegeneration and Visual Function

Histone methyltransferase Ezh2 coordinates mammalian axon regeneration via regulation of key regenerative pathways

Identifying Hmga2 preserving visual function by promoting a shift of Müller glia cell fate in mice with acute retinal injury

Directed robust generation of functional retinal ganglion cells from Müller glia

In vivo Regeneration of Ganglion Cells for Vision Restoration in Mammalian Retinas

Overlapping transcriptional programs promote survival and axonal regeneration of injured retinal ganglion cells

Ca2+/Calmodulin-Dependent Protein Kinase II Enhances Retinal Ganglion Cell Survival But Suppresses Axon Regeneration after Optic Nerve Injury

Group II metabotropic glutamate receptor agonist promotes retinal ganglion cell survival by reducing neuronal excitotoxicity in a rat chronic ocular hypertension model

Modulating amacrine cell-derived dopamine signaling promotes optic nerve regeneration and preserves visual function